Microbial contamination risks and clinical safety in platelet-rich plasma therapy and evaluation of rapid microbial

Anna Arita1, Yoshitomo Saita2, Naho Fujiwara3

  • 1Medical Technology Innovation Center, Juntendo University, A-Bld, 3F, 2-1-1 Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan.

Regenerative Therapy
|December 3, 2025
PubMed
Abstract

Insights

Microbial contamination risks exist during platelet-rich plasma (PRP) collection and preparation. Flow cytometry shows promise for detecting bacteria in PRP, but improved methods are needed to ensure patient safety and prevent infections.

Area of Science:

  • Microbiology
  • Biotechnology
  • Clinical Diagnostics

Background:

  • Platelet-rich plasma (PRP) is increasingly used for therapeutic purposes, including pain relief and wound healing.
  • Recent reports highlight concerns regarding post-therapy infections, necessitating an investigation into microbial contamination risks associated with PRP.

Purpose of the Study:

  • To assess microbial contamination risks during blood collection and PRP preparation.
  • To evaluate the efficacy of flow cytometry (FCM) and polymerase chain reaction (PCR) as rapid detection methods for microbial contaminants in PRP.

Main Methods:

  • Microbial contamination risks were assessed at venipuncture sites and in PRP preparation facilities.
  • The sensitivity of FCM and PCR for detecting inoculated microorganisms (e.g., *Staphylococcus aureus*, *Candida albicans*) in PRP and platelet-poor plasma (PPP) was compared.

Main Results:

  • Microbial colonies were detected at venipuncture sites in 60% of patients and in 67% of preparation facilities.
  • FCM detected microbial contamination at concentrations of 10^2-10^3 CFU/mL in PRP, with limitations in detecting *C. albicans*.
  • PCR showed high false-negative/positive rates in PRP samples, despite good sensitivity with pure cultures.

Conclusions:

  • Venipuncture and PRP production processes pose risks for microbial contamination.
  • Enhanced disinfection protocols and facility-specific measures are recommended to mitigate contamination.
  • FCM is a promising tool for detecting viable bacteria in PRP, though further improvements in sensitivity are required. Clinicians must remain vigilant for potential infections.